CINECA IRIS Institutional Research Information System

CIRRI, DAMIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.148
AS - Asia 2.268
EU - Europa 1.515
SA - Sud America 453
AF - Africa 123
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.054
SG - Singapore 732
IT - Italia 701
CN - Cina 592
BR - Brasile 365
HK - Hong Kong 301
VN - Vietnam 236
DE - Germania 127
SE - Svezia 127
FI - Finlandia 111
KR - Corea 95
FR - Francia 87
BG - Bulgaria 71
IN - India 71
JP - Giappone 70
CI - Costa d'Avorio 61
GB - Regno Unito 58
RU - Federazione Russa 51
CA - Canada 50
AR - Argentina 33
AT - Austria 29
TR - Turchia 29
NL - Olanda 25
BD - Bangladesh 23
IQ - Iraq 23
CZ - Repubblica Ceca 20
SN - Senegal 20
PL - Polonia 19
MX - Messico 18
CH - Svizzera 15
EC - Ecuador 15
ES - Italia 15
ID - Indonesia 14
BE - Belgio 10
VE - Venezuela 10
ZA - Sudafrica 10
IE - Irlanda 9
MA - Marocco 9
MY - Malesia 9
UA - Ucraina 9
UZ - Uzbekistan 9
GR - Grecia 8
PY - Paraguay 8
SA - Arabia Saudita 8
OM - Oman 7
PK - Pakistan 6
BO - Bolivia 5
CL - Cile 5
HN - Honduras 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
CO - Colombia 4
DZ - Algeria 4
EG - Egitto 4
IL - Israele 4
LT - Lituania 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RO - Romania 4
BS - Bahamas 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
PE - Perù 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
MN - Mongolia 1
NI - Nicaragua 1
Totale 7.514
Salva come PNG Salva come JPEG
Città #
Singapore 422
Ashburn 395
Hong Kong 298
Santa Clara 268
San Jose 254
Dallas 214
Fairfield 206
Woodbridge 149
Chandler 145
Hefei 130
Shanghai 126
Milan 116
Pisa 101
Council Bluffs 94
Seattle 93
Seoul 92
Helsinki 90
Houston 87
Livorno 86
Wilmington 85
Los Angeles 81
Beijing 78
Cambridge 73
Ho Chi Minh City 72
Sofia 71
Tokyo 63
Abidjan 61
Ann Arbor 61
New York 59
Boardman 54
Florence 47
Munich 43
Princeton 42
Lauterbourg 38
Serra 38
São Paulo 36
Hanoi 35
Lawrence 34
Rome 30
Frankfurt am Main 29
Medford 28
Bremen 26
Buffalo 24
Vienna 21
Dakar 20
London 20
Redondo Beach 19
Nanjing 16
Istanbul 15
Turku 15
Baltimore 14
Brno 14
Montreal 14
Vicopisano 14
Chennai 13
Fuzhou 13
Ottawa 13
Warsaw 13
Nuremberg 12
Ogden 12
Denver 11
Haiphong 11
Kent 11
Salvador 10
San Diego 10
Amsterdam 9
Da Nang 9
Quanzhou 9
Tashkent 9
Wuhan 9
Baghdad 8
Boulder 8
Brussels 8
Chicago 8
Des Moines 8
Lucca 8
Mexico City 8
San Giuliano Terme 8
Zurich 8
Atlanta 7
Bern 7
Boston 7
Brantford 7
Dong Ket 7
Fortaleza 7
Orem 7
Porto Alegre 7
Rio de Janeiro 7
Washington 7
Columbus 6
Dublin 6
Figino 6
Paris 6
Prato 6
Pune 6
Quito 6
Belo Horizonte 5
Betim 5
Bexley 5
Brasília 5
Totale 5.134
Salva come PNG Salva come JPEG
Nome #
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent 209
Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug-Resistant Pathogens: Structure–Activity Relationships 209
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 208
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 204
PtI2(DACH), the Iodido Analogue of Oxaliplatin as a Candidate for Colorectal Cancer Treatment: Chemical and Biological Features 193
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 187
An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies 181
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 180
New gold carbene complexes as candidate anticancer agents 175
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues 174
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 174
Exploring the interaction between a fluorescent Ag(I)-biscarbene complex and non-canonical DNA structures: a multi-technique investigation 173
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues 164
Protein metalation by two structurally related gold(I) carbene complexes: An ESI MS study 156
Triethylphosphine gold iodide (I), the iodido analogue of Auranofin: comparative studies of a potential antineoplastic agent 153
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 150
Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS 148
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 147
Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles 145
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 145
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation 144
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 140
Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs 138
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments 137
Synthesis, Chemical Characterization, and Biological Evaluation of Hydrophilic Gold(I) and Silver(I) N-Heterocyclic Carbenes as Potential Anticancer Agents 136
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 135
Structural Characterization of a Gold/Serum Albumin Complex 134
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 134
An unprecedented palladium-arsenic catalytic cycle for nitriles hydration 127
Reactions of medicinal gold(III) compounds with proteins and peptides explored by electrospray ionization mass spectrometry and complementary biophysical methods 127
Non‐medical applications of inorganic medicines. A switch based on mechanistic knowledge 125
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 125
Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety 123
Reevaluating the Mechanistic Insights of α-TOS-Bearing Pt(IV) Anticancer Complexes: A New Perspective from a More In-Depth Knowledge 122
A biophysical study of the interactions of palladium(II), platinum(II) and gold(III) complexes of aminopyridyl-2,2'-bipyridine ligands with RNAs and other nucleic acid structures 122
Computationally enhanced X-ray diffraction analysis of a gold(III) complex interacting with the human telomeric DNA G-quadruplex. Unravelling non-unique ligand positioning 121
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 120
Pd(II)/1,10-phenanthroline complexes bearing arene ligands: On the role of N- vs O-coordination to tune their cellular activity and binding ability towards DNA and RNA 119
Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs 117
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 117
Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity 116
Strategies for the improvement of metal-based chemotherapeutic treatments 114
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 106
Auranofin and its analogs as prospective agents for the treatment of colorectal cancer 105
Trans-Pd(II) complexes: A different approach for the development of promising anticancer drugs 104
Arsenoplatin-ferritin nanocage: Structure and cytotoxicity 103
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 103
Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System 102
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 96
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study 94
On the mechanism of action of arsenoplatins: arsenoplatin-1 binding to a B-DNA dodecamer 88
Kinetic and structural analysis of the inactivation of urease by mixed-ligand phosphine halide Ag(I) complexes 83
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 76
Hydrophobic gold nanoparticles coupled with fluorescent dyes: A smart tool for optoelectronic applications 74
null 66
Is the Next Cisplatin Already in Our Laboratory? 66
Procedimento catalitico per la preparazione di ammidi 61
Redefining platinum(IV) chemotherapy: α-tocopherol succinate functionalization and nanoparticle encapsulation to improve cisplatin- and oxaliplatin-based therapies 51
Mechanistic Fingerprints from Chloride to Iodide: Halide vs. Ammonia Release in Platinum Anticancer Complexes 45
null 41
Ligand‐Dependent DNA Binding and Cytotoxicity of Palladium(II) Complexes 37
Thiosugar-functionalized gold(I)-NHC complexes as selective anticancer agents for potential targeted therapy 34
Engineering oxaliplatin(IV) prodrugs with monohaloacetates for redox-responsive and multimodal anticancer activity 24
Totale 7.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.640
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022368 9 11 16 13 61 57 13 14 30 25 28 91
2022/2023687 67 73 37 52 47 62 22 49 199 20 20 39
2023/2024535 51 47 60 33 66 76 45 14 16 10 54 63
2024/20252.075 11 59 14 101 186 207 256 93 215 236 268 429
2025/20263.036 228 347 337 384 225 198 407 211 205 251 97 146
Totale 7.827